Basavaiah K, Nagegowda P
Department of P.G. Studies and Research in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India.
Farmaco. 2004 Feb;59(2):147-53. doi: 10.1016/j.farmac.2003.11.012.
Four new methods using titrimetry and spectrophotometry are described for the determination of ranitidine hydrochloride (RNH) with potassium bromate as the oxidimetric reagent and acid dyes, methyl orange, indigo carmine and metanil yellow. In direct titrimetry (method A), the drug is titrated directly with bromate in acid medium and in the presence of excess of bromide using methyl orange indicator. In back titrimetry (method B), the drug is treated with a measured excess of bromate in the presence of bromide and acid, and the unreacted bromine is determined iodometrically. Both spectrophotometric methods are based on the oxidation of RNH by a known excess of bromate in acid medium and in the presence of excess of bromide followed by estimation of surplus oxidant by reacting with either indigo carmine (method C) or metanil yellow (method D), and measuring the absorbance at 610 or 530 nm. In methods B, C and D, reacted oxidant corresponds to the drug content. The experimental conditions are optimized. Titrimetric procedures are applicable over the ranges 1-10 mg (A) and 1-17 mg (B), and the reaction stoichiometry is found to be 1:1 (BrO(-)(3): RNH). In spectrophotometric methods, the absorbance is found to increase linearly with increasing concentration of RNH, which is corroborated by the calculated correlation coefficient (r) of 0.9984 (C) and 0.9976 (D). The systems obey Beer's law for 2-12 and 1-7 microg ml(-1), for methods C and D, respectively. Method D with a molar absorptivity of 9.82 x 10(4) l mol(-l) cm(-1) is found to be more sensitive than method C ( epsilon = 2.06 x l0(4) l mol(-1) cm(-1)). The limits of detection and quantification are reported for both the spectrophotometric methods. The proposed methods were applied successfully to the determination of RNH in tablets and injections. The reliability of the assay was established by parallel determination by the official method and by recovery studies.
本文描述了四种采用滴定法和分光光度法的新方法,用于测定盐酸雷尼替丁(RNH),以溴酸钾作为氧化试剂,并使用酸性染料甲基橙、靛蓝胭脂红和间胺黄。在直接滴定法(方法A)中,药物在酸性介质中,在过量溴化物存在下,以甲基橙为指示剂,直接用溴酸盐滴定。在返滴定法(方法B)中,药物在溴化物和酸存在下,用计量过量的溴酸盐处理,未反应的溴用碘量法测定。两种分光光度法均基于在酸性介质中,在过量溴化物存在下,用已知过量的溴酸盐氧化RNH,然后通过与靛蓝胭脂红(方法C)或间胺黄(方法D)反应来测定剩余氧化剂,并在610或530nm处测量吸光度。在方法B、C和D中,反应的氧化剂与药物含量相对应。优化了实验条件。滴定法适用于1 - 10mg(A)和1 - 17mg(B)的范围,反应化学计量比为1:1(BrO₃⁻:RNH)。在分光光度法中,吸光度随RNH浓度增加呈线性增加,计算得到的相关系数(r)为0.9984(C)和0.9976(D),证实了这一点。方法C和D的体系分别在2 - 12和1 - 7μg ml⁻¹范围内符合比尔定律。发现方法D的摩尔吸光系数为9.82×10⁴ l mol⁻¹ cm⁻¹,比方法C(ε = 2.06×10⁴ l mol⁻¹ cm⁻¹)更灵敏。报告了两种分光光度法的检测限和定量限。所提出的方法成功应用于片剂和注射液中RNH的测定。通过与官方方法平行测定和回收率研究确定了该测定方法的可靠性。